Provenance du réseau au premier degré de Steven Caffé
Entité | Type d'entité | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 29 | |
Public Company | Biotechnology | 22 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Steven Caffé via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member Director of Finance/CFO | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Director of Finance/CFO | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Tech/Sci/R&D Officer President Human Resources Officer Sales & Marketing | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree | |
AUTOLUS THERAPEUTICS PLC | Biotechnology | General Counsel Chairman Public Communications Contact General Counsel | |
University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Pharmaceuticals: Major | Chairman President Chief Operating Officer | |
University of Pennsylvania | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Worcester Polytechnic Institute | College/University | Undergraduate Degree Undergraduate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree | |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
INCYTE CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA. | Biotechnology | Chairman Director/Board Member | |
UROGEN PHARMA LTD. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Euro Ventures, Inc. | Chairman Founder | ||
AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
OSIRIS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Antipodean Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Villanova University | College/University | Masters Business Admin Undergraduate Degree | |
FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree | |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Chairman Private Equity Investor | |
KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
The Leonard N Stern School of Business | College/University | Undergraduate Degree Masters Business Admin | |
Versant Venture Capital VI (Canada) LP
Versant Venture Capital VI (Canada) LP Investment ManagersFinance Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA. | Investment Managers | Director/Board Member Director/Board Member | |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
ARIX BIOSCIENCE PLC | Investment Managers | Director/Board Member Director/Board Member | |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO |
Statistiques
Internationale
Etats-Unis | 42 |
Royaume-Uni | 6 |
Canada | 3 |
Suisse | 3 |
Sectorielle
Health Technology | 31 |
Consumer Services | 12 |
Commercial Services | 5 |
Finance | 4 |
Process Industries | 2 |
Opérationnelle
Director/Board Member | 303 |
Corporate Officer/Principal | 162 |
Independent Dir/Board Member | 100 |
Chairman | 57 |
Director of Finance/CFO | 49 |
Relations les plus connectées
Insiders | |
---|---|
Bradley Bolzon | 41 |
Timothy Walbert | 40 |
John Johnson | 40 |
Thomas Woiwode | 39 |
Kurt von Emster | 34 |
Peter Greenleaf | 31 |
Robert Spiegel | 30 |
Karen Smith | 29 |
Paul Edick | 27 |
Peter Kiener | 25 |
Maureen O'Connell | 24 |
Pablo Cagnoni | 24 |
Cary Claiborne | 19 |
Matthias Alder | 18 |
Peter Pfreundschuh | 17 |
- Bourse
- Insiders
- Steven Caffé
- Connexions Sociétés